CLINICAL_TRIALS
trial_result
· 2014-08-11
Clinical Trial Update: RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer [Phase 2]
Summary
Phase 2 trial of everolimus (RAD001) in previously treated metastatic pancreatic cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-11